@article{d47e10ae68db4123bffb3e2d82d6c70b,
title = "Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study",
abstract = "Background: The rapid increase in mobile telephone use has generated concern about possible health risks of radiofrequency electromagnetic fields from these devices. Methods: A case-control study of 1105 patients with newly diagnosed acoustic neuroma (vestibular schwannoma) and 2145 controls was conducted in 13 countries using a common protocol. Past mobile phone use was assessed by personal interview. In the primary analysis, exposure time was censored at one year before the reference date (date of diagnosis for cases and date of diagnosis of the matched case for controls); analyses censoring exposure at five years before the reference date were also done to allow for a possible longer latent period. Results: The odds ratio (OR) of acoustic neuroma with ever having been a regular mobile phone user was 0.85 (95% confidence interval 0.69-1.04). The OR for ≥10 years after first regular mobile phone use was 0.76 (0.52-1.11). There was no trend of increasing ORs with increasing cumulative call time or cumulative number of calls, with the lowest OR (0.48 (0.30-0.78)) observed in the 9th decile of cumulative call time. In the 10th decile (≥1640. h) of cumulative call time, the OR was 1.32 (0.88-1.97); there were, however, implausible values of reported use in those with ≥1640. h of accumulated mobile phone use. With censoring at 5 years before the reference date the OR for ≥10 years after first regular mobile phone use was 0.83 (0.58-1.19) and for ≥1640. h of cumulative call time it was 2.79 (1.51-5.16), but again with no trend in the lower nine deciles and with the lowest OR in the 9th decile. In general, ORs were not greater in subjects who reported usual phone use on the same side of the head as their tumour than in those who reported it on the opposite side, but it was greater in those in the 10th decile of cumulative hours of use. Conclusions: There was no increase in risk of acoustic neuroma with ever regular use of a mobile phone or for users who began regular use 10 years or more before the reference date. Elevated odds ratios observed at the highest level of cumulative call time could be due to chance, reporting bias or a causal effect. As acoustic neuroma is usually a slowly growing tumour, the interval between introduction of mobile phones and occurrence of the tumour might have been too short to observe an effect, if there is one.",
keywords = "Acoustic neuroma, Brain tumour, Epidemiology, Mobile phones, Radiofrequency electromagnetic fields, Vestibular schwannoma",
author = "{The INTERPHONE Study Group} and E. Cardis and I. Deltour and M. Vrijheid and Evrard, {A. S.} and M. Sanchez and M. Moissonnier and B. Armstrong and J. Brown and G. Giles and J. Siemiatycki and L. Nadon and Parent, {M. E.} and D. Krewski and McBride, {M. M.} and C. Johansen and Christensen, {H. C.} and A. Auvinen and P. Kurttio and A. Lahkola and T. Salminen and M. Hours and M. Bernard and L. Montestruq and J. Sch{\"u}z and M. Blettner and G. Berg-Beckhoff and B. Schlehofer and S. Sadetzki and A. Chetrit and A. Jarus-Hakak and S. Lagorio and I. Iavarone and T. Takebayashi and N. Yamaguchi and A. Woodward and A. Cook and N. Pearce and T. Tynes and L. Kl{\ae}boe and Blaasaas, {K. G.} and M. Feychting and S. L{\"o}nn and A. Ahlbom and McKinney, {P. A.} and Hepworth, {S. J.} and Muir, {K. R.} and Swerdlow, {A. J.} and Schoemaker, {M. J.}",
note = "Funding Information: Anders Ahlbom is principal investigator and Maria Feychting co-investigator of the Swedish part of the COSMOS study, an international cohort study of mobile phone use and health. Funding of the Swedish part of COSMOS comes from the Swedish Research Council, AFA Insurance ( http://www.afaforsakring.se/WmTemplates/Page.aspx?id=2602 ), and VINNOVA (The Swedish Governmental Agency for Innovation Systems, http://www.vinnova.se/In-English/About-VINNOVA/ ). VINNOVA received funds for this purpose from TeliaSonera, Ericsson AB and Telenor. The provision of funds to the COSMOS study investigators via VINNOVA is governed by agreements that guarantees COSMOS{\textquoteright} complete scientific independence. Funding Information: The Swedish centre was additionally supported by the Swedish Research Council and the Swedish Cancer Society . Funding Information: The Canadian centres in Ottawa/Vancouver were supported by a university–industry partnership grant from the Canadian Institutes of Health Research (CIHR), the latter including partial support from the Canadian Wireless Telecommunications Association . The CIHR university–industry partnerships program also includes provisions that ensure complete scientific independence of the investigators. D. Krewski is the Natural Sciences and Engineering Research Council of Canada Chair in Risk Science at the University of Ottawa. Funding Information: The Canada – Montreal study was primarily funded by a grant from the Canadian Institutes of Health Research (project 15 MOP-42525). Additionally, Dr Siemiatycki's research team was partly funded by the Canada Research Chair programme and by the Guzzo-CRS Chair in Environment and Cancer. Dr Parent had a salary award from the Fonds de la recherche en sant{\'e} du Qu{\'e}bec. Funding Information: The Finnish Interphone study received additional national funding from Emil Aaltonen Foundation and Academy of Finland (Grant No. 80921 ). Funding Information: The Japanese Interphone study was fully funded by the Ministry of Internal Affairs and Communications of Japan. Funding Information: The UK North study received additional funding from the Health and Safety Executive, the Department of Health, the Mobile Telecommunications, Health and Research (MTHR) program, and the Scottish Executive. The University of Leeds received some financial support on behalf of the 4 centres of the {\textquoteleft}UK North Study{\textquoteright} from the UK Network Operators (O2, Orange, T-Mobile, Vodafone, {\textquoteleft}3{\textquoteright}) under legal signed contractual agreements which guaranteed complete independence for the scientific investigators. Funding Information: Additional funding for the study in France was provided by l{\textquoteright}Association pour la Recherche sur le Cancer (ARC) [Contrat No. 5142] and three network operators (Orange, SFR, Bouygues T{\'e}l{\'e}com). The funds provided by the operators represented 5% of the total cost of the French study and were governed by contracts guaranteeing the complete scientific independence of the investigators. Funding Information: Funding in New Zealand for this project was provided by the Health Research Council of New Zealand, the Cancer Society of New Zealand, the Wellington Medical Research Foundation, the Hawke's Bay Medical Research Foundation and the Waikato Medical Research Foundation. Funding Information: The German Interphone study received additional national funding from the “Deutsches Mobilfunkforschungsprogramm [German Mobile Phone Research Program]” of the German Federal Ministry of Environment, Nuclear Safety, and Nature Protection; the Ministry of Environment and Traffic of the state of Baden-W{\"u}rttemberg; the Ministry of Environment of the state of North Rhine-Westphalia; and the MAIFOR Programme of the University of Mainz. Publisher Copyright: {\textcopyright} 2011 Elsevier Ltd.",
year = "2011",
month = oct,
doi = "10.1016/j.canep.2011.05.012",
language = "English",
volume = "35",
pages = "453--464",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier",
number = "5",
}